Fresh analysis indicates that patients who come off popular GLP-1 drugs like Mounjaro or Wegovy can put back on lost weight much more quickly than those who end traditional lifestyle regimens.
Findings released in a major health publication points out that while overweight individuals often shed substantial amounts of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"Users buying such medications must be informed of the danger of fast rebound weight gain when the treatment concludes," warns lead investigator Dr. Susan Jebb.
Such speed of recovery implies a return to pre-treatment mass in about 18 months.
Comparing Treatments
The research, which looked at 37 of trials involving thousands of participants, contrasted the effects of these new drugs with older methods.
Researchers emphasize that individuals who shed pounds through lifestyle changes alone typically see a more gradual creep back—approximately 100 grams monthly—once they finish.
Explaining the Quick Regain
Experts suggest the way of the jabs explains the amplified regain.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Artificially providing GLP-1 levels far above than the body's typical production may cause the system to produce less of its own natural GLP-1, and could reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics expert.
"Stopping of this GLP-1 'fix' results in hunger is no longer kept in check, making binge eating much more probable."
An Ongoing Disease?
Health authorities advise the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Professionals argue that, given the significant potential of weight regain, the therapy should be considered long-term.
This opinion is reinforced by drug manufacturers, who state that the results "underscore the persistent nature of excess weight," similar to managing diseases like diabetes.
Patient Testimonies
Individuals who have stopped the jabs describe a powerful resurgence of appetite.
"It felt as if a switch that goes on and I was suddenly ravenous," described one woman.
This difficulty is worsened if patients have not established sustainable lifestyle or habit modifications during therapy.
Widespread Interest
Survey data suggest that a significant number of adults in the UK have tried these injections in the past year, with interest continuing to grow.
- Use is more common among women compared to men.
- The middle-aged demographic shows the greatest level of interest.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while these medications are potent tools for weight loss, they are not a standalone fix and lasting health benefits likely depends on ongoing lifestyle management.
